$159.81
1.76% yesterday
Nasdaq, Aug 12, 10:00 pm CET
ISIN
US6323071042
Symbol
NTRA

Natera, Inc. Stock price

$159.81
+1.63 1.03% 1M
-12.14 7.06% 6M
+1.51 0.95% YTD
+44.56 38.66% 1Y
+104.64 189.67% 3Y
+106.32 198.77% 5Y
+143.46 877.43% 10Y
+137.07 602.77% 20Y
Nasdaq, Closing price Tue, Aug 12 2025
+2.77 1.76%
ISIN
US6323071042
Symbol
NTRA
Industry

Key metrics

Basic
Market capitalization
$21.4b
Enterprise Value
$20.5b
Net debt
positive
Cash
$991.6m
Shares outstanding
135.9m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
11.7 | 10.5
EV/Sales
11.2 | 10.1
EV/FCF
241.0
P/B
17.3
Financial Health
Equity Ratio
72.0%
Return on Equity
-15.9%
ROCE
-16.6%
ROIC
-33.9%
Debt/Equity
0.1
Financials (TTM | estimate)
Revenue
$1.8b | $2.0b
EBITDA
$-194.0m | $-302.8m
EBIT
$-227.2m | $-347.6m
Net Income
$-189.8m | $-305.0m
Free Cash Flow
$85.2m
Growth (TTM | estimate)
Revenue
51.5% | 20.0%
EBITDA
45.5% | -58.3%
EBIT
40.6% | -56.4%
Net Income
48.1% | -60.1%
Free Cash Flow
143.1%
Margin (TTM | estimate)
Gross
61.8%
EBITDA
-10.6% | -14.9%
EBIT
-12.4%
Net
-10.4% | -15.0%
Free Cash Flow
4.7%
More
EPS
$-1.4
FCF per Share
$0.6
Short interest
2.8%
Employees
4k
Rev per Employee
$380.0k
Show more

Is Natera, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,027 stocks worldwide.

Natera, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

28 Analysts have issued a Natera, Inc. forecast:

26x Buy
93%
1x Hold
4%
1x Sell
4%

Analyst Opinions

28 Analysts have issued a Natera, Inc. forecast:

Buy
93%
Hold
4%
Sell
4%

Financial data from Natera, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
1,831 1,831
52% 52%
100%
- Direct Costs 700 700
16% 16%
38%
1,131 1,131
86% 86%
62%
- Selling and Administrative Expenses 914 914
38% 38%
50%
- Research and Development Expense 445 445
36% 36%
24%
-194 -194
46% 46%
-11%
- Depreciation and Amortization 33 33
27% 27%
2%
EBIT (Operating Income) EBIT -227 -227
41% 41%
-12%
Net Profit -190 -190
48% 48%
-10%

In millions USD.

Don't miss a Thing! We will send you all news about Natera, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Natera, Inc. Stock News

Positive
Invezz
4 days ago
Shares of genetic testing company Natera (NASDAQ:NTRA) jumped sharply in morning trading, rising as much as 17% after the company reported better-than-expected second-quarter 2025 financial results and raised its full-year revenue forecast. The stock later closed at 7.7% in the green.
Neutral
Seeking Alpha
5 days ago
Natera, Inc. (NASDAQ:NTRA ) Q2 2025 Earnings Conference Call August 6, 2025 4:30 PM ET Company Participants Alexey Aleshin - GM of Oncology and ECD & Chief Medical Officer Michael B. Brophy - Chief Financial Officer Solomon Moshkevich - President of Clinical Diagnostics Steven Leonard Chapman - CEO & Director Conference Call Participants Catherine Walden Ramsey Schulte - Robert W.
Positive
The Motley Fool
5 days ago
Natera (NTRA) Q2 Revenue Jumps 32%
More Natera, Inc. News

Company Profile

Natera, Inc. is a diagnostics company, which engages in the discovery, development, and commercialization of genetic testing services. It provides Panorama non-invasive prenatal test (NIPT), Vistara, horizon carrier screening (HCS), spectrum pre-implantation genetic screening and spectrum pre-implantation genetic diagnosis, Anora products of conception (POC) and non-invasive paternity testing (PAT). The firm also offers Constellation, a cloud-based software product that allows laboratory customers to gain access to the algorithms and bioinformatics in order to validate and launch tests based on the technology. The company was founded by Matthew Rabinowitz and Jonathan Sheena in November 2003 and is headquartered in San Carlos, CA.

Head office United States
CEO Stephen Chapman
Employees 4,429
Founded 2004
Website www.natera.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today